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Abstract
Background—With limited screening options, early detection of gynaecologic cancers can 
depend on women recognizing the potential significance of symptoms and seeking care.
Objective—We investigated women’s concern about symptoms that might be related to 
gynaecologic cancers, the underlying conditions they associated with symptoms and their actual 
and hypothetical response to symptoms.
Methods—Fifteen focus groups with women aged 40–60 years were conducted in Chicago, Los 
Angeles, Miami and New York City. Participants were given an untitled list of symptoms that 
could indicate various gynaecologic cancers and asked if any would concern them, what could 
cause each and what they would do if they experienced any of them.
Results—Overall, participants expressed greater concern about symptoms clearly gynaecologic 
in nature than other symptoms. Participants generally did not associate symptoms with any form 
of cancer. Some women who had experienced symptoms reported waiting an extended period 
before seeking care or not seeking care at all. The belief that a symptom indicated a benign 
condition was the most common reason given for delaying or foregoing care seeking. Strategies 
participants reported using to supplement or replace consultations with health care providers 
included Internet research and self-care.
Conclusion—Raising awareness of symptoms that can indicate gynaecologic cancers may lead 
to earlier detection and improved survival. In particular, women should be informed that 
gynaecologic cancers can cause symptoms that may not seem related to the reproductive organs 
(e.g. back pain) and that unusual vaginal bleeding should prompt them to seek care immediately.
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Introduction
Of the five main gynaecologic cancers—cervical, ovarian, uterine, vaginal and vulvar—
population-based screening is recommended only for cervical cancer, using the 
Papanicolaou (Pap) test.1 As a result, early detection of most gynaecologic cancers can 
depend on women recognizing the potential significance of symptoms and seeking care.2 
Unfortunately, symptoms associated with gynaecologic cancers are often non-specific and 
associated with a variety of benign conditions3,4 (Table 1). US women’s awareness of 
gynaecologic cancer symptoms has been found to be low.5–8 In the case of ovarian cancer, 
gastrointestinal symptoms were often unrecognized by patients as a serious concern,9 and 
women were less likely to seek care for symptoms they perceived to be unrelated to the 
reproductive system, compared with those perceived to be gynaecologic in nature.10
To increase women’s awareness of gynaecologic cancers, their symptoms and risk factors, 
the Centers for Disease Control and Prevention (CDC), in collaboration with the Department 
of Health and Human Services’ Office on Women’s Health, created the Inside Knowledge: 
Get the Facts About Gynecologic Cancer campaign.11 Inside Knowledge supports the 
Gynecologic Cancer Education and Awareness Act of 2005,12 or Johanna’s Law, passed by 
Congress in 2006, and signed into law in 2007. The primary messages of this national, 
multimedia initiative include the following: pay attention to your body and know what is 
normal for you, gynaecologic cancers have warning signs and get a Pap test regularly to 
screen for cervical cancer. To date, Inside Knowledge has released public service 
announcements in several formats, including broadcast, print and out-of-home displays (e.g. 
on buses and in shopping malls), as well as a variety of patient education materials.
This focus group study was undertaken to supplement the limited available literature and 
inform the continued development of Inside Knowledge as well as other related public health 
initiatives. The analyses described here explored women’s concern about symptoms that can 
indicate gynaecologic cancers, the underlying conditions they associated with symptoms and 
their actual and hypothetical responses to symptoms.
Methods
Fifteen focus groups with 132 women were conducted in 2009. Groups were held in 
Chicago (4 groups, 34 participants), Los Angeles (3 groups, 27 participants), Miami (4 
groups, 36 participants) and New York City (4 groups, 35 participants). These cities were 
selected based on the diversity of their geographic region and demographic composition.
Participants
Participants were limited to women aged 40 to 60 years, the primary population initially 
targeted by the Inside Knowledge campaign. Women with a personal or family history of 
gynaecologic cancers were excluded; however, in a few instances participants divulged such 
history during groups, contradicting information they gave during enrolment in the study.
Participants were recruited using public information (e.g. published telephone numbers) and 
proprietary lists by the private research facilities where the groups were conducted. A 
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minimum of seven and a maximum of nine participants were included in each focus group. 
To allow for participants who failed to report as scheduled, up to 12 participants were 
invited to each focus group. When more participants reported than were needed, decisions 
about which individuals to retain were based primarily on maximizing demographic 
diversity.
Procedure
Each focus group lasted 1½ to 2 hours and was led by a professional moderator using a 
semi-structured discussion guide. Three or more investigators monitored each group from 
behind a one-way mirror. Before taking part in the study, each woman signed a consent form 
disclosing the rights of participants, data handling and reporting procedures and the use of 
audio recording. During her introductory remarks, the moderator reiterated the voluntary 
nature of participation and informed participants of the presence of investigators behind the 
one-way mirror. To ensure anonymity, only first names were displayed on participants’ 
name cards; participants were instructed to use only their first names during the groups; and 
identifying information was not provided to investigators. To defray the costs associated 
with attendance, participants received a small honorarium, the amount of which was 
consistent with federally sponsored research. Participants also received a packet of Inside 
Knowledge educational materials.
At the beginning of each group, participants were given a list of symptoms associated with 
cervical, ovarian, uterine, vaginal and vulvar cancers. The list was not titled, and the 
moderator was instructed not to use the term ‘symptom’ during the discussion. To mitigate 
any order effects, the sequence in which symptoms were listed was rotated midway through 
the study, after the eighth focus group. The symptoms listed were drawn from CDC’s Inside 
Knowledge campaign materials,13 which are based on expert recommendations and existing 
scientific evidence: (1) ‘bleeding or discharge from your vagina that is not normal for you’; 
(2) ‘changes in the color of the skin of the vulva or a rash, sores, or warts on the vulva’ (as 
reported elsewhere,8 participants’ understanding of the term ‘vulva’ was evaluated); (3) 
‘itching or burning in the genital area that does not go away’; (4) ‘pain or pressure in the 
pelvic area (the area below your stomach and between your hip bones)’; (5) ‘back or 
abdominal pain’; (6) ‘being tired all the time’; (7) ‘a change in your bathroom habits, such 
as having to pass urine very badly or very often’; and (8) ‘bloating, which is when the area 
below your stomach swells or feels full’.
In response to the symptoms list, participants indicated in writing which would most 
concern them. Next, the moderator asked participants to discuss why the symptoms they 
selected would be of concern and what could cause symptoms. Then, the moderator asked 
participants about their actual response to symptoms they had experienced and their 
hypothetical response to symptoms they had not experienced.
Analysis
An inductive (data-driven) thematic approach was primarily used to develop the codes 
included in the analysis. In addition, several codes were suggested by the existing literature, 
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investigators’ interest and social cognitive theory,14 which is the guiding theoretical 
framework of CDC’s Inside Knowledge campaign.
Verbatim transcripts of focus groups were compiled using the audio recordings. After 
reviewing several transcripts and the notes of the investigators who observed the groups, the 
lead investigator drafted the initial codebook, which listed code names (e.g. ‘symptom is 
concerning because it may signify a serious underlying condition’), definitions and coding 
instructions. A companion coding form with codes organized by theme was developed using 
Microsoft Word. A participant utterance or unbroken unit of speech was the coding 
segmentation unit analysed, and participant utterances were numbered in sequential order in 
each transcript. Moderator utterances were not numbered or coded but were included on the 
coding form if needed for context. Transcripts were coded by electronically ‘cutting’ a 
section of text with utterance numbers and ‘pasting’ it onto the coding form next to all 
relevant codes.
The initial codebook and coding form were refined through an iterative process in which 
four investigators—two primary coders and two consultants—independently coded the same 
three randomly selected transcripts, compared coding forms, clarified code definitions and 
revised the codebook accordingly. Then, the two primary coders independently coded the 12 
remaining transcripts in random order. After coding each transcript, the primary coders 
reconciled all coding discrepancies, the vast majority of which were the result of one coder 
missing a valid code detected by the other. In rare instances in which the primary coders 
could not resolve a coding dispute (<1% of coding discrepancies), one of the consultants 
cast the deciding vote. No new codes were added or other major revisions made to the 
codebook after the seventh transcript. The final codebook included 85 codes related to the 
topics reported here. The coding forms of the first six transcripts coded were updated to 
reflect the final codebook. Intercoder reliability between the two primary coders was 
evaluated using Cohen’s Kappa15 for the 12 transcripts coded after the initial codebook 
development process and ranged from 0.79 (standard error [SE] = 0.0061) to 0.90 (SE = 
0.0057) with a median of 0.89.
As recommended by Krueger and Casey,16 the frequency of responses is described here 
using general terms rather than actual counts. Analyses of response frequencies revealed 
natural clusters of codes in terms of the number of participants who mentioned them and the 
number of groups in which they were identified. A code attributed to ‘many’ participants 
indicates it was mentioned in at least half of the groups by 22 to 40 women, the modifier 
‘some’ indicates a code was mentioned in at least a quarter of the groups by 12 to 18 
women, ‘few’ indicates a code was mentioned by 3 to 10 women and ‘very few’ indicates 
that a code was mentioned by 1 or 2 women. The consistency of findings across cities was 
evaluated, and no differences were noted (data not shown).
Cohesion refers to participants’ comfort and engagement in group activities17 and is an 
indicator of focus group data quality.18 Five interaction scenarios were monitored as proxies 
of cohesion: a participant sharing personal health experiences, agreeing with another, 
disagreeing with another, interacting directly with another (without the moderator’s 
involvement) and referring to another by name. In every focus group, the majority of 
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participants shared personal health experiences and two or more agreed with the opinions of 
another, disagreed with the opinions of another and interacted with each other directly 
without the moderator intervening. In 14 of the 15 groups, one or more participants referred 
to another by name.
Results
Participant characteristics
Participants included a diverse group of women aged 40–60 years (Table 2). All participants 
said they had at least one Pap test in the past, and most (87.1%) reported they had a Pap test 
within the past 3 years.
Symptom concern
Of the symptoms tested, participants reported the greatest concern about unusual vaginal 
bleeding, changes in the skin of the vulva, and vaginal itching or burning (Table 3). 
Participants said they were least concerned about bloating, having to pass urine very badly 
or more often than usual and being tired all the time. Many women reported that concern 
about a specific symptom was related to their perception of the seriousness of the underlying 
conditions they associated with it, the severity of the symptom, the pain and discomfort it 
caused and its impact on their day-to-day lives. Their comments reflected these associations:
• With the bleeding, I would think cancer, and I would go to the doctor immediately.
• You could spot for several reasons, and it wouldn’t be that big of an issue. But 
heavy bleeding would concern me.
• If I feel pain, it’s time to call somebody immediately.
• New York is not the friendliest bathroom place in the whole wide world so the fact 
that I’d need to go to bathroom frequently or badly while I was out and about 
would really upset me.
Underlying conditions associated with symptoms
Most participants did not report specific causes associated with symptoms, despite probes 
from the moderator. These participants often attributed symptoms to ‘something serious’ or 
‘nothing serious’. However, the specific causes mentioned by the minority of participants 
were generally accurate.
Unusual vaginal bleeding was the only symptom tested that participants attributed to cancer 
with any consistency, with some noting it could indicate cervical cancer. A few participants 
specifically stated that they did not associate the symptoms with any form of cancer (‘None 
of these would make me think cancer’). However, many participants recognized that unusual 
vaginal bleeding and changes in the skin of the vulva could suggest ‘something serious’. 
Recognition that other symptoms could signal a significant health issue was not as 
widespread.
Cooper et al. Page 5
Fam Pract. Author manuscript; available in PMC 2015 June 24.
A
uthor M
anuscript
A
uthor M
anuscript
A
uthor M
anuscript
A
uthor M
anuscript
Actual and hypothetical care seeking
In response to symptoms they had actually experienced, some reported not seeking care at 
all or waiting for an extended period, even years, before seeking care. Others reported that 
they sought care after a few days, and several said they sought immediate care due to severe 
pain resulting from symptoms.
Hypothetical care seeking for the symptoms studied also varied. Changes in the skin of the 
vulva elicited the most consistent and timely predicted response of the symptoms tested, 
with no women reporting that they would wait more than ‘a couple of weeks’ to seek care. 
However, a few participants qualified their response, noting they probably would not notice 
this symptom, as their genitals are not readily visible. For the other symptoms tested, the 
timing of predicted care seeking ranged from immediate (‘I would go as soon as possible’) 
to never (‘I would just live with that’).
The most commonly reported factor prompting timely care seeking in response to both 
actual and hypothetical symptoms was concern that a symptom signalled a serious 
underlying condition (Table 4). When women said they had waited longer or would wait 
longer to seek care than the intervals suggested in Table 1, they attributed their delay to 
belief that the symptom was related to a benign cause, a personal tendency to delay or avoid 
care seeking in general, cost concerns and the absence of discomfort or tolerable discomfort.
In response to symptoms associated with the reproductive organs, such as unusual vaginal 
bleeding and changes in the skin of the vulva, participants typically said they had consulted 
or would consult a gynaecologist or primary care physician. Most who mentioned consulting 
a primary care physician for such symptoms explained that they received gynaecologic care 
from their primary care physician or that their insurance plan required that a primary care 
physician make specialist referrals.
For the remaining symptoms, participants generally said they had consulted or would 
consult a primary care physician. However, a few participants reported they would consult 
specialists (e.g. a urologist, for the condition of having to urinate more often than usual).
Also, a few participants reported that they had sought or would seek treatment in a hospital 
emergency room in response to a symptom (gynaecologic or other). Typically, participants 
reported that severe pain would prompt them to seek emergency care. Others said they 
would go to the emergency room because getting an appointment with their doctor would 
take too long.
Other care-seeking strategies
To supplement or replace consultation with a health care provider, participants discussed 
several strategies they had or would use in response to symptoms (Table 5). The most 
commonly mentioned were Internet research (typically using Google searches or WebMD), 
self-care and discussion with family members or friends. Many participants said they used 
such strategies before contacting health care providers. Use of Internet research and 
consultations with friends and family were also reported after scheduling a visit with a 
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health care provider in order to prepare questions. A few participants reported using the 
Internet after an appointment to research diagnoses.
Not all participants endorsed use of the supplemental strategies mentioned. A minority said 
that they would not research symptoms on the Internet (‘The Internet is too scary’), use self-
care (‘I would take the wrong medicine and make things worse’), or discuss symptoms with 
family members or friends (‘It’s best not to discuss that kind of intimate information with 
friends’).
Discussion
Our findings suggest several factors that may impede care seeking for symptoms associated 
with gynaecologic cancers. First, women in our study were largely unaware of the symptoms 
related to gynaecologic cancers, and many said they would not seek timely care if they 
experienced the symptoms studied. In addition, we found that a personal tendency to delay 
or avoid care seeking in general, cost concerns and an ability to tolerate discomfort or pain 
may represent additional barriers to early detection of gynaecologic cancers.
Consistent with prior research,9 participants were most concerned about symptoms clearly 
related to their reproductive organs, such as unusual vaginal bleeding or vaginal itching or 
burning. Participants more often associated these symptoms with serious underlying 
conditions, compared with other symptoms discussed. However, unusual vaginal bleeding 
was the only symptom that participants consistently associated with any form of cancer. 
Many participants were unaware that some symptoms, such as back pain, bloating and 
urinating more often than usual, could be associated with any serious underlying conditions.
Some participants who reported experiencing symptoms never sought care, and others 
delayed seeking care for extended periods, even years. However, women who were aware 
that the symptoms studied could be associated with a gynaecologic cancer tended to report 
that they did or would seek timely care. For instance, a participant reported she did not seek 
care for persistent, severe back pain for several months; then she learned that it could 
indicate ovarian cancer and sought care immediately.
Our study is subject to the limitations and strengths intrinsic to all qualitative methods. 
Given the low number of participants and use of convenience sampling, inferences about 
qualitative results cannot be made in the same way as with quantitative data. Although a 
diverse group of women participated in this study, they are not necessarily representative of 
all US women. Also, qualitative methods cannot produce firm counts or percentages to 
characterize response volume, as not every participant responds to every point of 
discussion.16 One notable advantage of focus groups is that the open-ended interaction 
among participants facilitates the collection of data with nuances and depth that are not 
possible to obtain through quantitative methods.
Clearly, efforts are needed to educate women about gynaecologic cancer symptoms and 
when to seek care. At the same time, it is important to emphasize that some symptoms 
associated with gynaecologic cancers may result from many benign conditions. Routine 
medical examinations and Pap tests provide opportunities to educate women about the 
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absence of population-based screening tests for ovarian, uterine, vaginal and vulvar cancers 
and the symptoms that may be associated with gynaecologic cancers—particularly those 
seemingly unrelated to the reproductive organs and unusual vaginal bleeding, which should 
prompt immediate care seeking.
Significant decreases in gynaecologic cancer morbidity and mortality may ultimately depend 
on the development and uptake of population-based prevention and screening modalities and 
improved treatments. The human papillomavirus vaccine, now available for males as well as 
females, offers protection against cervical, vulvar, vaginal and anal cancers.19 Ongoing 
investigations of ovarian cancer markers may result in a viable population-based screening 
modality in the future.20 In the meantime, educating women about gynaecologic cancer 
symptoms offers a potential pathway to earlier diagnosis and improved survival.
Human Subjects Review
Compliant with Code of Federal Regulations, Title 45, Part 46, The Public Health Service 
Act as amended by the Health Research Extension Act of 1985, Public Law 99–158,21 the 
protocol of this study was submitted to the Institutional Review Board for CDC’s National 
Center for Chronic Diseases Prevention and Health Promotion and was determined to be a 
public health practice activity on 20 June 2008. This determination was applied because the 
primary purpose of the study was to inform development of, and improve, a public health 
program, CDC’s Inside Knowledge: Get the Facts About Gynecologic Cancer campaign. 
The US Office of Management and Budget reviewed the burden to participants taking part 
in focus group studies supporting cancer prevention and control communication campaigns 
and approved the study protocol on 9 January 2009.
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Table 1
Gynaecologic cancer symptoms and appropriate timing of care seeking
Cancer Symptoms When care should be sought
Cervical • Unusual vaginal bleeding or discharge Two weeks after onset for all symptoms, except 
unusual vaginal bleeding, for which immediate care 
should be sought
Ovarian • Pelvic or abdominal pain or pressure
• Back pain
• Bloating
• Having to urinate more frequently or urgently than usual
• Unusual vaginal bleeding (especially post-menopause) or 
discharge
Uterine • Unusual vaginal bleeding (especially post-menopause or 
bleeding between periods, periods that are either longer or 
heavier than normal)
• Pelvic or abdominal pain.
Vaginal • Unusual vaginal bleeding (especially after sex)
• Having to urinate more frequently or urgently than usual
Vulvar • Itching of the vulva that does not go away
• Changes in the colour of the vulva, so that it looks redder or 
whiter than usual
• A rash or sore on the vulva that does not go away
Source: Centers for Disease Control and Prevention. Gynecologic cancer symptoms. Atlanta, Georgia: US Department of Health and Human 
Services. Available at: http://www.cdc.gov/cancer/gynecologic/basic_info/symptoms.htm
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Table 2
Participant demographics (N = 132)
%
Metropolitan area of residence Chicago 25.8
Los Angeles 20.5
Miami 27.3
New York City 26.5
Age* 40–44 years 20.5
45–49 years 25.8
50–54 years 31.1
55–60 years 22.7
Race/ethnicity White 40.2
Black 32.6
Hispanic 18.9
Asian 8.3
Highest level of education attained Did not complete high school 7.6
High school graduate/GED 21.2
2-year college program graduate/technical school graduate 12.9
Some college (less than 4-year degree) 15.9
4-year college degree graduate 35.6
Advanced degree 6.8
Employment Full time 56.1
Part time 22.0
Not employed 19.7
Retired 2.3
Annual household income Less than $25 000 15.2
$25 000–$39 999 19.7
$40 000–$64 999 28.8
$65 000–$99 999 25.0
$100 000 or more 11.4
Marital status Married 44.7
Single 33.3
Divorced 15.2
Separated 3.0
Widowed 3.1
Other 0.8
Health insurance for routine care Yes 81.8
No 18.2
Pap test within last 3 years Yes 87.1
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%
No 11.4
Not sure 1.5
*
Participants were limited to women aged 40–60 years.
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Table 3
Underlying causes that participants associated with symptoms*
Symptoms in
descending
order of
concern
Participants who mentioned†
Many Some Few Very few
Unusual 
vaginal 
bleeding or 
discharge
• Unspecified 
cause of 
concern/
‘something 
serious’
• Cervical cancer
• Fibroid tumour/cyst
• Ovarian cancer
• Uterine cancer
• Unspecified 
cancer
• Perimenopause
• Unspecified cause 
of no concern/
‘nothing serious’
• Fallopian tube 
cancer
• Vaginal cancer
• Pelvic cancer
• Stomach cancer
• Throat cancer
• Endometriosis
• Sexually 
transmitted 
disease (STD)
• Kidney stones
• Gallstones
• ‘Rupture’
• Laceration (‘cut’)
• Bladder infection
• Yeast infection
• Menstruation
• Normal aging
• ‘Not cancer’
Changes in 
the skin of the 
vulva
• Unspecified 
cause of 
concern/
‘something 
serious’
• Unspecified STD • Herpes
• Allergic reaction 
to antibiotic or 
detergent
• Unspecified 
cancer
• Unspecified cause 
of no concern/
‘nothing serious’
• ‘Not cancer’
• Cervical cancer
• Ovarian cancer
• Uterine cancer
• Vaginal cancer
• Breast cancer
• Skin cancer
• Throat cancer
• Stomach cancer
• Human 
papillomavirus/
‘papilloma 
cancer’
• Chlamydia
• Genital warts
• Fibroid tumour/
cyst
• Jaundice/kidney 
problems
• Hypertension
• Yeast infection
• Bladder infection
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Symptoms in
descending
order of
concern
Participants who mentioned†
Many Some Few Very few
• Diet
• Insect bite
• Normal aging
Vaginal 
itching or 
burning
— • Yeast infection/ 
infection
• Unspecified cause 
of concern/
‘something serious’
• Herpes
• Allergic reaction 
to detergent or 
perfume
• Unspecified STD
• Unspecified cause 
of no 
concern/’nothing 
serious’
• ‘Not cancer’
• Ovarian cancer
• Unspecified 
cancer
• Diabetes
• Urinary tract 
infection
• Premenstrual 
syndrome
• Poor hygiene
• Normal aging
Pain or 
pressure in 
the pelvic 
area
— • Unspecified cause 
of concern/
‘something serious’
• Cervical cancer
• Ovarian cancer
• Unspecified STD
• Unspecified cause 
of no concern/
‘nothing serious’
• Uterine cancer
• Colon cancer
• Breast cancer
• Throat cancer
• Tubal pregnancy
• Arthritis
• Fibroid tumour/
cyst
• Appendicitis
• Gallstones
• Hypertension
• Sciatica
• Urinary tract 
infection
• Premenstrual 
syndrome
• Perimenopause
• Menstruation
• Exercise/
overexertion
• ‘Gas’
• Normal aging
• ‘Not cancer’
Back or 
abdominal 
pain
— • Unspecified cause 
of concern/
‘something serious’
• Injury/
overexertion
• Appendicitis
• Menstruation
• Normal aging
• Unspecified 
cancer
• Cervical cancer
• Ovarian cancer
• Uterine cancer
• Pancreatic cancer
• Breast cancer
• Colon cancer
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Symptoms in
descending
order of
concern
Participants who mentioned†
Many Some Few Very few
• Unspecified cause 
of no concern/
‘nothing serious’
• Stomach cancer
• Arthritis
• Diabetes
• Ovarian cyst
• Kidney stones
• Kidney disorder/
infection
• Fibroid tumour/
cyst
• Herniated disc
• Hypertension
• Premenstrual 
syndrome
• Perimenopause
• Curvature of the 
spine
• ‘Gas’
• Diet
• Lack of exercise
• Pregnancy/labour
• ‘Not cancer’
Being tired all 
the time
— • Fatigue/not 
sleeping enough
• Unspecified cause 
of no concern/
‘nothing serious’
• Diet/vitamin 
deficiency
• Unspecified cause 
of concern/
‘something 
serious’
• ‘Not cancer’
• Ovarian cancer
• Prostate cancer
• Colon cancer
• Esophageal 
cancer
• Throat cancer
• Unspecified 
cancer
• Heart disease
• Kidney stones
• Anaemia
• Premenstrual 
syndrome
• Common cold
• Medication side 
effect
Having to 
pass urine 
very badly or 
more often 
than usual
— — • Urinary tract 
infection
• Kidney disorder/
problem
• Unspecified cause 
of concern/
‘something 
serious’
• Ovarian cancer
• Vaginal cancer
• Colon cancer
• Diabetes
• Liver disease
• Hypertension
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Symptoms in
descending
order of
concern
Participants who mentioned†
Many Some Few Very few
• Unspecified cause 
of no concern/
‘nothing serious’
• ‘Cyst’
• Premenstrual 
syndrome
• Menopause
• Consuming a lot 
of fluids
• Diet
• Normal aging
• ‘Not cancer’
Bloating — — • Ovarian cancer
• Menstruation
• Diet
• Unspecified 
cancer
• Unspecified cause 
of concern/
‘something 
serious’
• Unspecified cause 
of no concern/
‘nothing serious’
• Uterine cancer
• Cervical cancer
• Colon cancer
• Stomach cancer
• Fibroid tumour/
cyst
• Premenstrual 
syndrome
• Normal aging
• ‘Gas’
• Pregnancy
• ‘Not cancer’
*
Reported underlying causes that are not generally associated with symptoms are italicized. When interpreting this table, it is important to consider 
that topics of less concern were the subject of fewer comments during focus groups.
†
Because focus group results are not generalizable and not every participant voices an opinion on every topic discussed, the frequency of responses 
is described using modifiers such as ‘many’, ‘some’ and ‘few’, rather than counts or percentages.16
Note: — indicates there are no responses in this cell.
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Table 4
Factors influencing timing of actual and hypothetical care seeking in response to symptoms
Factor Participants who
mentioned*
Example
Care seeking 
within 
appropriate 
interval†
Concern that symptom 
indicates a serious underlying 
condition
Many If I had bleeding, if I had itching or burning, if I had to go to the 
bathroom a lot, I’d call my gynecologist. To me, these are all the 
symptoms of ovarian cancer.
Personal tendency to seek 
care promptly
Some When I find something wrong, I call the doctor and I go. I don’t 
second guess. I don’t go to Google. I’m going to a doctor.
Pain Some In the past I have gone to the emergency room for unbearable pain.
Concern that symptom 
indicates worsening of an 
existing condition or the 
recurrence of a past condition
Few Bloating, that would probably be number one [the most concerning 
symptom] because, you know, of a condition I do have. I have 
fibroids.
Delayed care 
seeking and 
failure to seek 
care
Belief that symptom is 
associated with a benign 
cause
Many A lot of these things are normal, based on like everyday things, like 
what you ate or what you did. I am not concerned about those.
Personal tendency to delay or 
avoid care seeking
Some Well, I’ve had the bleeding after my period, and I guess because I 
don’t like doctors, I didn’t go. I just waited to see. And then I waited 
and waited until it finally went away.
Cost concerns Some I have insurance, but my deductible is $6,000. … That affects my 
decision [whether or not to seek care].
Lack of discomfort/tolerable 
discomfort
Few If something is bothering me, then I am going to go [to the doctor]. If 
it is not it’s not painful, I don’t.
*
Because focus group results are not generalizable and not every participant voices an opinion on every topic discussed, the frequency of responses 
is described using modifiers such as ‘many’, ‘some’ and ‘few’, rather than counts or percentages.16
†
‘Appropriate interval’ was defined as 2 weeks after symptom onset for all symptoms, with the exception of unusual vaginal bleeding for which 
immediate care should be sought.5
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Table 5
Strategies used to supplement or replace consultations with health care providers
Strategy Participants who mentioned*
Before contacting
provider
In preparation of
scheduled visit
After visit Would not use
Internet research Many Some Few Some
Self-care, including over-the-counter medication Many — — Few
Consultation with lay family members or friends Many Few — Few
Consultation with family members or friends who are medical 
professionals
Some Few — —
Consultation with pharmacist Few — — —
*
Because focus group results are not generalizable and not every participant voices an opinion on every topic discussed, the frequency of responses 
is described using modifiers such as ‘many’, ‘some’ and ‘few’, rather than counts or percentages.16
Note: — indicates there are no responses in this cell.
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